Asim Lal
Overview
Explore the profile of Asim Lal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mauck M, Zhao Y, Goetzinger A, Tungate A, Spencer A, Lal A, et al.
Reg Anesth Pain Med
. 2023 Jun;
49(2):79-86.
PMID: 37364919
Introduction: Major traumatic injuries are a known risk factor for persistent opioid use, but data describing the relationship between specific traumatic injuries and opioid use is lacking. Methods: We used...
2.
Schrank T, Landess L, Stepp W, Rehmani H, Weir W, Lenze N, et al.
Mol Cancer Res
. 2022 Jun;
20(10):1489-1501.
PMID: 35731223
Implications: HPV16 genotype is a potential biomarker that could be easily adopted to guide therapeutic decision-making related to deescalation therapy.
3.
Schrank T, Weir W, Lal A, Landess L, Lenze N, Hackman T
Laryngoscope Investig Otolaryngol
. 2021 Dec;
6(6):1376-1382.
PMID: 34938877
Objectives: HPV-associated (p16+) squamous cell carcinoma of the oropharynx (OPSCC) has improved survival as compared to HPV-negative, smoking-associated disease. Intermediate outcomes have been noted in patients with p16+ tumors and...
4.
Schrank T, Lenze N, Landess L, Hoyle A, Parker J, Lal A, et al.
Cancer
. 2021 Apr;
127(15):2788-2800.
PMID: 33819343
Background: Human papillomavirus-positive (HPV+) squamous cell carcinoma of the oropharynx (OPSCC) is the most prevalent HPV-associated malignancy in the United States. Favorable treatment outcomes have led to increased interest in...